Kirk Rorrer
About Kirk Rorrer
Kirk Rorrer is the Associate Director of Cmc Project Management at Bristol-Myers Squibb and Celgene, with a background in project management and research in the pharmaceutical industry.
Company
Kirk Rorrer currently works at Bristol-myers Squibb as Associate Director, Cmc Project Management in New Jersey, United States. Additionally, he holds a similar position at Celgene in Summit, New Jersey, United States. His role involves overseeing aspects of project management within the context of Chemistry, Manufacturing, and Controls (CMC).
Previous Work Experience
Kirk Rorrer has an extensive work history. From 2018 to 2019, he served as a Senior Project Manager at Nanostring Technologies, Inc. in Seattle, Washington. Prior to that, he spent four years at Milliporesigma in Burlington, Massachusetts, as a Senior Project Manager from 2014 to 2018. He also worked as a Team Lead at Amgen in Thousand Oaks, California, from 2009 to 2014. His earlier roles include Senior Researcher at Trubion Pharmaceuticals (2006-2009), Scientist at Mds Pharma Services (2004-2006), and Research Associate II at Amgen (2000-2004). He gained early career experience as a Summer Fellow at the University of Washington in 2009.
Education and Expertise
Kirk Rorrer completed his Master of Business Administration from the University of Washington - Michael G. Foster School of Business in 2011. He holds a Master of Science in Pharmacology from Virginia Commonwealth University School of Medicine, obtained in 2000. He also earned a Bachelor of Science in Biochemistry from Virginia Tech in 1995. His areas of expertise include Value Stream Mapping, Biological Potency Assays, Competitive Intelligence, Financial Modeling, and In Vitro Diagnostics.
Professional Skills
Kirk Rorrer is skilled in various professional methodologies and practices. He has expertise in Value Stream Mapping, a lean-management method for analyzing and designing future states for processes in order to improve efficiency. He specializes in Biological Potency Assays and has significant experience in Competitive Intelligence. Additionally, he is proficient in Financial Modeling and experienced in In Vitro Diagnostics, involving tests done on blood or tissue samples taken from the human body.